The overexpression of HLA-E is predictive of poor prognostic outcomes in patients with different tumors (e.g., OC, GBM, CRC, RCC, and NSCLC) [150,151,152,153,154,155]. Here, HLA-E is linked to non-small cell lung carcinoma.